A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy

Trial Profile

A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy

Discontinued
Phase of Trial: Phase III

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Droxidopa (Primary)
  • Indications Orthostatic hypotension
  • Focus Registrational; Therapeutic Use
  • Acronyms PHOENIX
  • Sponsors Chelsea Therapeutics
  • Most Recent Events

    • 07 Jan 2016 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 18 Jun 2015 Pooled cardiovascular safety analysis, results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
    • 23 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top